Conversion from Sandimmune to Neoral in stable liver graft recipients.
作者信息
Pollard S G, Lodge J P
机构信息
Department of Transplantation Surgery, St. James's University Hospital, Leeds, United Kingdom.
出版信息
Transplant Proc. 1996 Aug;28(4):2244-6.
PMID:8769213
Abstract
摘要
相似文献
1
Conversion from Sandimmune to Neoral in stable liver graft recipients.
Transplant Proc. 1996 Aug;28(4):2244-6.
2
Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.稳定的肾移植受者从传统的山地明转换为新山地明治疗。
Transplant Proc. 1996 Aug;28(4):2199-201.
3
4
5
Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353.稳定期肾移植受者从山地明转换为新山地明。山德士研究组OLN - 353。
Transplant Proc. 1996 Aug;28(4):2196-8.
6
Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.
Transplant Proc. 1996 Aug;28(4):2169-70.
7
Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.病例研究：稳定的肾移植受者从山地明转换为新山地明。
Transplant Proc. 1996 Aug;28(4):2219-20; discussion 2218.
8
Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.病例研究：一名肝移植患者从环孢素山地明转换为新山地明。
Transplant Proc. 1996 Aug;28(4):2252-3.
9
Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.稳定期肝移植患者从环孢素（山地明）转换为环孢素（新山地明）的安全性。
Transplant Proc. 1998 Aug;30(5):1852-3. doi: 10.1016/s0041-1345(98)00455-2.
10
Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.心脏移植受者中环孢素山地明与微乳剂新山地明的药代动力学、血流动力学及代谢效应比较
J Heart Lung Transplant. 1997 Aug;16(8):787-94.
引用本文的文献
1
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.环孢素：基于微乳剂的制剂（新山地明）在器官移植中药物动力学特性、临床疗效及耐受性的最新综述
Drugs. 2001;61(13):1957-2016. doi: 10.2165/00003495-200161130-00006.
Zotero 插件